News Johnson & Johnson

Equities

JNJ

US4781601046

Market Closed - Nyse Other stock markets 04:00:02 2024-05-28 pm EDT			5-day change	1st Jan Change
144.4 ^USD	-1.76%		-4.55%	-7.89%

May. 28	Sector Update: Health Care Stocks Fall Late Afternoon	MT
May. 28	Sector Update: Health Care Stocks Retreat Tuesday Afternoon	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sector Update: Health Care Stocks Fall Late Afternoon	May. 28	MT
Sector Update: Health Care Stocks Retreat Tuesday Afternoon	May. 28	MT
Sector Update: Health Care	May. 28	MT
Bio-Thera, Stada Enter Deal for Biosimilar Candidate to Johnson & Johnson's Simponi in EU, UK	May. 28	MT
Johnson & Johnson Agrees to Buy Numab Unit, Investigational Skin Disease Treatment For $1.25 Billion	May. 28	MT
Top Midday Stories: Wall Street Returns to T+1 Settlements; T-Mobile Buys US Cellular's Wireless Ops; Energy Transfer Buys WTG Midstream; GameStop Extends Rally	May. 28	MT
Johnson & Johnson to Acquire Experimental Eczema Drug for $1.25 Billion	May. 28	MT
Johnson & Johnson to Acquire Experimental Eczema Drug for $1.25 Billion	May. 28	MT
Johnson & Johnson Acquires Experimental Eczema Drug for $1.25 Billion	May. 28	MT
J&J: acquisition of Swiss eczema biotech company	May. 28	CF
J&J to Acquire Skin Disease Treatment Rights from Numab in $1.25 Billion Deal	May. 28	DJ
J&J acquires rights to skin disorder drug for $1.25 bln	May. 28	RE
Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermatitis	May. 28	AQ
Johnson & Johnson to Obtain Rights to a Clinical-Stage Bispecific Antibody to Address Distinct Patient Needs in Atopic Dermatitis	May. 28	BU
Johnson & Johnson: Meet a nurse who leads clinical trials to find innovative cancer therapies	May. 24	AQ
J&J: to present advances at ASCO and EHA	May. 24	CF
Johnson & Johnson : advances leadership in oncology innovation with more than 75 clinical study and real-world presentations at ASCO and EHA	May. 24	PU
Some of the biggest splits in Corporate America	May. 23	RE
Cancer victims sue Johnson & Johnson over 'fraudulent' bankruptcies	May. 22	RE
Johnson & Johnson Allegedly Engaged in 'Bad Faith' Bankruptcies That Harm Talc Victims, Lawsuit Says	May. 22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 12:30 pm EST